Arkolith/Insider Trading/SNSE/Form 4

Cambrian BioPharma Inc

10% OwnerSensei Biotherapeutics, Inc. (SNSE) · full profile →Form 4 · filed Dec 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$233K
Net Open-Market Flow
-$233K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 5, 2025Sell(S)15K$11.40$165K163K
Dec 5, 2025Sell(S)42$13.16$553161K
Dec 5, 2025Sell(S)2K$12.29$21K161K
Dec 4, 2025Sell(S)5K$9.06$45K178K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000897069-25-001776) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML